Vice President Kim Young-gwan Buys 2,000 Shares of Company Stock… Small but Shows Management Confidence


  • Vice President Kim Young-gwan purchased 2,000 common shares on the open market on May 29, 2026, at 3,885 KRW per share, increasing his total holdings from 33,000 to 35,000 shares (0.17% ownership).
  • The purchase price (3,885 KRW) is 2.8% above the base date closing price (3,780 KRW), indicating management's view of undervaluation and confidence in future growth.
  • Although the amount is small (approx. 7.77M KRW) and has limited short-term price impact, the insider buying suggests a commitment to responsible management and shareholder value enhancement.
  • [AI Comprehensive Analysis]This disclosure involves a small-scale insider stock purchase with negligible direct market impact, but it provides a positive signal of management confidence. However, with only a 0.17% stake, there is no structural change such as control shift or capital raising, so a sharp short-term price rally is unlikely.

KOSPI Filing Information


  • Filing: Report on Ownership of Specific Securities by Executives and Major Shareholders
  • Company: Kukje Pharma (002720)
  • Submission: Gim Yeong-gwan
  • Receipt: 05-29-2026